Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -1.82x is 47% above its 5-year average of -3.44x, around the middle of its 5-year range (-98.23x–61.78x).
117.14% below its 12-month average of 10.62x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -2.57x.
INTEREST COVERAGE RATIO
-1.82x
INTEREST COVERAGE RATIO AVG TTM
10.62x
INTEREST COVERAGE RATIO AVG 3Y
-22.72x
INTEREST COVERAGE RATIO AVG 5Y
-3.44x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-117.14%
CURRENT VS 3Y AVG
+91.99%
CURRENT VS 5Y AVG
+47.15%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.21x
median of 340 covered companies
CURRENT VS SECTOR MEDIAN
+56.77%
vs the sector median at left
Definitive Healthcare Corp.
Market Cap
$104.85M
Interest Coverage Ratio
-1.82x
TTM Avg
10.62x
3Y Avg
-22.72x
5Y Avg
-3.44x
Market Cap
$105.03M
Interest Coverage Ratio
-5.63x
TTM Avg
53.06x
3Y Avg
67.81x
5Y Avg
43.09x
Market Cap
$102.66M
Interest Coverage Ratio
N/A
TTM Avg
2.91x
3Y Avg
2.91x
5Y Avg
2.91x
Market Cap
$108.20M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$99.48M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$110.75M
Interest Coverage Ratio
-1.15x
TTM Avg
4.51x
3Y Avg
6.93x
5Y Avg
222.11x
Market Cap
$111.78M
Interest Coverage Ratio
N/A
TTM Avg
30.61x
3Y Avg
29.12x
5Y Avg
24.09x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Definitive Healthcare Corp. (DH) | $104.85M | -1.82x | 10.62x | -22.72x | -3.44x |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $105.03M | -5.63x | 53.06x | 67.81x | 43.09x |
| The Joint Corp. (JYNT)vs › | $102.66M | N/A | 2.91x | 2.91x | 2.91x |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $108.20M | N/A | N/A | N/A | N/A |
| Immunic, Inc. (IMUX)vs › | $108.97M | N/A | N/A | N/A | N/A |
| Korro Bio, Inc. (KRRO)vs › | $100.55M | N/A | N/A | N/A | N/A |
| Anixa Biosciences, Inc. (ANIX)vs › | $99.48M | N/A | N/A | N/A | N/A |
| Apyx Medical Corporation (APYX)vs › | $110.75M | -1.15x | 4.51x | 6.93x | 222.11x |
| BGM Group Ltd. (BGM)vs › | $111.78M | N/A | 30.61x | 29.12x | 24.09x |
| Lucid Diagnostics Inc. (LUCD)vs › | $111.89M | -2256.36x | N/A | N/A | N/A |
Interest Coverage
-1.8x
Debt/Equity
1.15
Current Ratio
1.86
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -2.57x |
| 2026-03-31 | -1.84x |
| 2025-12-31 | 61.78x |
| 2025-09-30 | -2.90x |
| 2025-06-30 | -1.39x |
| 2025-03-31 | -75.95x |
| 2024-12-31 | -28.37x |
| 2024-09-30 | -60.11x |
| 2024-06-30 | -98.23x |
| 2024-03-31 | -4.26x |
| 2023-12-31 | -2.59x |
| 2023-09-30 | -75.80x |
| 2023-06-30 | -3.18x |
| 2023-03-31 | -3.40x |
| 2022-12-31 | -7.11x |
| 2022-09-30 | -3.27x |
| 2022-06-30 | -4.30x |
| 2022-03-31 | -5.92x |
| 2021-12-31 | -7.58x |
| 2021-09-30 | -0.56x |
| 2021-09-17 | -0.80x |
| 2021-03-31 | -0.26x |
| 2020-12-31 | -0.80x |
| 2020-09-30 | -0.10x |
